Skip to main content


  • AddRemove
  • Build a Report 
News Releases

Mayer Brown advises Sauflon Pharmaceuticals on US$1.2 billion sale to The Cooper Companies, Inc

1 July 2014
London - Leading global law firm Mayer Brown has advised the founders and majority shareholders of global manufacturer and distributor of soft contact lenses and aftercare solutions, Sauflon Pharmaceuticals, in its sale to The Cooper Companies, Inc. (NYSE: COO), a US listed global medical device company, for US$1.2 billion.

Established in 1985, Sauflon is a privately-owned British company and is one of only four companies to manufacture contact lenses and aftercare solutions. It has three state-of-the-art manufacturing plants, sales offices in over 10 countries, and products sold in over 50 countries
Peter Dickinson, London head of Corporate & Securities at Mayer Brown, commented: "Sauflon has been a leading provider of contact lenses and aftercare solutions for nearly three decades and we are very pleased to have assisted the founders and majority shareholders in the sale of Sauflon to CooperVison.”

The Mayer Brown team was led by London head of Corporate & Securities Peter Dickinson and included Corporate & Securities senior associate Katherine Woods, Tax Transactions & Consulting consultant Peter Steiner and Employment & Benefits partner Andrew Stanger.

Media Contact

  • Helen Obi
    Senior Corporate Communications & PR Manager
    T +44 20 3130 8527
  • Katie Tibbitts
    Senior PR Executive
    T +44 20 3130 8120

Related Information

  • Related People
    Peter Dickinson
    T +44 20 3130 3747
    Katherine Woods
    T +44 20 3130 3711
    Andrew Stanger
    Legal Professional / Consultant
    T +44 20 3130 3934

The Build a Report feature requires the use of cookies to function properly.  Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently.  If you do not accept cookies, this function will not work.  For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.